Publications by authors named "Jiayuan Niu"

An increasing number of elderly individuals are experiencing postoperative cognitive dysfunction (POCD) problems after undergoing hip replacement surgery, with gut microbiota metabolites playing a role in its pathogenesis. Among these, the specific effects of trimethylamine N-oxide (TMAO) on POCD are still unclear. This study aimed to explore the role of TMAO on cognitive dysfunction and underlying mechanisms in mice.

View Article and Find Full Text PDF

Immune checkpoint blockade therapy represented by programmed cell death ligand 1 (PD-L1) inhibitor for advanced renal carcinoma with an objective response rate (ORR) in patients is less than 20%. It is attributed to abundant tumoral vasculature with abnormal structure limiting effector T cell infiltration and drug penetration. We propose a bispecific fibrous glue (BFG) to regulate tumor immune and vascular microenvironments simultaneously.

View Article and Find Full Text PDF

Post-conditioning with sevoflurane, a volatile anesthetic, has been proved to be neuroprotective against hypoxic-ischemic brain injury (HIBI). Our previous research showed that autophagy is over-activated in a neonatal HIBI rat model, and inhibition of autophagy confers neuroprotection. There is increasing recognition that autophagy can be stimulated by activating endoplasmic reticulum (ER) stress.

View Article and Find Full Text PDF

Neonatal hypoxic-ischemic (HI) brain injury is associated with long-term neurological disorders, and protective strategies are presently scarce. Sodium 4-phenylbutyrate (4-PBA) reportedly acts as a chemical chaperone that alleviates endoplasmic reticulum (ER) stress, which plays a critical role in neurological diseases. The present study aimed to evaluate the neuroprotective effects of 4-PBA on HI-induced neonatal brain injury in a rat model, and to characterize possible underlying mechanisms.

View Article and Find Full Text PDF
Article Synopsis
  • Microglia/macrophages show different polarization patterns after ischemic events, which can influence recovery based on the disease context; this study focuses on how sevoflurane post-conditioning affects these immune cells following hypoxic-ischemic brain injury (HIBI) in neonatal rats.
  • Using a HIBI model, researchers examined the impact of sevoflurane on microglial/macrophage polarization and identified mechanisms linked to autophagy and the enzyme cathepsin B, analyzing various cell markers to assess neuroprotection and neuronal health.
  • Results indicated that sevoflurane treatment reduced inflammatory markers and neuronal cell death after HIBI, leading to improved long-term cognitive outcomes
View Article and Find Full Text PDF
Article Synopsis
  • The study examines the effects of sevoflurane post-conditioning (SPC) on hypoxic-ischemic brain injury (HIBI) in neonatal rats, focusing on autophagy's role and the Ezh2-regulated Pten/Akt/mTOR pathway.
  • Inhibition of excessive autophagy was found to provide neuroprotection, as evidenced by improved neuronal density and morphology following SPC treatment.
  • The research concluded that SPC protects against HIBI by modulating the Pten/Akt/mTOR signaling pathway through Ezh2, which helps reduce over-activated autophagy in the hippocampus.
View Article and Find Full Text PDF

Hypoxic-ischemic brain injury (HIBI) in neonates is one of the major contributors of newborn death and cognitive impairment. Numerous animal studies have demonstrated that autophagy is substantially increased in HIBI and that sevoflurane postconditioning (SPC) can attenuate HIBI. However, if SPC-induced neuroprotection inhibits autophagy in HIBI remains unknown.

View Article and Find Full Text PDF